Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS AUGUST ISSUE PUBLISHED
  • AUGUST 2020 Issue has been successfully launched on 1 August 2020.

Abstract

DEVELOPMENT OF RESVERATROL RAFT-FORMING CHEWABLE TABLETS WITH ACID NEUTRALIZING AND ANTI-INFLAMMATORY PROPERTIES

Kantaphon Chuaybamrung, Titayachat Mattapun, Worrawee Siripruekpong, Kanidta Kaewkroek and Ruedeekorn Wiwattanapatapee*

ABSTRACT

Raft-forming chewable tablet formulations incorporating resveratrol solid dispersion were developed to achieve prolonged drug delivery in the stomach and increase the effectiveness of gastric ulcer treatment. Solid dispersions of resveratrol in Eudragit® EPO or polyvinyl pyrrolidone K-30 were prepared first to improve the solubility of resveratrol and the optimum weight ratio of 1:7 resveratrol to Eudragit® EPO was selected to incorporate into raft-forming tablets. All tablet formulations were prepared by direct compression using sodium alginate or pectin as a gel-forming agent and hydroxypropyl methylcellulose as a release retarding polymer. Raft buoyancy was achieved by adding calcium carbonate and sodium bicarbonate as porogens. The optimized formulations formed a gelled raft in 30 sec in 0.1 N hydrochloric acid (pH 1.2) which remained buoyant and released more than 70% of resveratrol within 8 h. The formulations were capable of effective acid neutralization (6.18 mEq (Alginate#2), 8.02 mEq (Pectin#2)). Formation of a raft barrier on top of the gastric content is expected to prevent or reduce symptoms of gastroesophageal reflux disease. The formulations based on alginate and pectin exhibited potent anti-NO activity with IC50 values of 34.2 ± 0.6 μg/mL and 24.8 ± 0.4 μg/mL respectively, compared with indomethacin (14.4 ± 0.6 μg/mL).

Keywords: Raft-forming systems, Alginate, Pectin, Resveratrol, Gastric ulcers.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More